March 13th 2023
ICLs offer a strong surgical correction option for some patients.
March 9th 2023
EnVision Summit 2023: Unique program takes family friendly conference to new heightsFebruary 13th 2023
Bonnie An Henderson, MD, founder and program director of EnVision Summit, previews what attendees can expect at this year’s meeting - from its diverse faculty to an inclusive Youth Program, while also giving back to the community. The conference will take place February 17 to 20 at the El Conquistador Resort in Fajardo, Puerto Rico.
Angiogenesis 2023: Ophthalmic artery angioplasty to treat age-related macular degenerationFebruary 10th 2023
In a presentation at Bascom Palmer’s 2023 Angiogenesis, Exudation, and Degeneration conference in Miami, Pedro Lylyk, MD, said ophthalmic artery angioplasty could prove to be a treatment option for patients diagnosed with age-related macular degeneration.
Glaucoma 360: Home tonometry - worth the pressure?February 4th 2023
Robert L. Stamper, MD, discusses some of the devices in development for measuring patients' intraocular pressure outside of doctors' office hours in his presentation at Glaucoma Research Foundation's annual Glaucoma Symposium.
Glaucoma 360: An update on IOLs - when and how to use themFebruary 4th 2023
Shan C. Lin, MD, provides an overview of the various intraocular lens technologies that are available, as well as considerations for contrast sensitivity and vision loss in patients at Glaucoma Research Foundation's annual Glaucoma Symposium.
Glaucoma 360: A bird's-eye view of innovationFebruary 3rd 2023
Kristen H. Ingenito, MBA, vice president and director of ophthalmics at Market Scope, discusses the volume of ophthalmologists offering interventional glaucoma treatment as well as emerging therapies in her presentation at the Glaucoma 360 New Horizons Forum.
Harrow announces permanent, product-specific J-Code for chloroprocaine hydrochloride ophthalmic gel for ocular surface anesthesiaFebruary 2nd 2023
The company noted that the product is a sterile, single-patient use, physician administered, ophthalmic gel preparation, containing no preservatives, that is safe and effective for ocular surface anesthesia.
Study: Hispanic and Black patients who underwent retinal detachment surgery had worse vision results than white patientsJanuary 19th 2023
Investigators found that all patients had similar single surgery success rates but that minority patients had significantly worse vision outcomes and were more likely to have multiple retinal breaks.
Study: Visual decreases within a day after uneventful phacoemulsification surgeryJanuary 11th 2023
With the safety and efficacy of phacoemulsification having increased to the point that it is no longer standard practice to examine patients the day after surgery, clinicians may be unfamiliar with the potential causes of reduced vision when presented with a patient in the immediate postoperative period.
Not only is canaloplasty designed to treat the entire conventional outflow pathway, facilitating flow through the trabecular meshwork, Schlemm canal, and collector channels, but it does so without a stent and without removing tissue.
Wilmer Eye Institute, Bascom Palmer take top honors in Ophthalmology Times' 2022 Best Programs AwardsDecember 19th 2022
Survey of academic chairs and residency directors recognizes centers of excellence in Best Clinical Care, Best Residency, Best Research, and Best Overall Programs.
EyeCon 2022: Ophthalmology Times co-chairs discuss highlights of Day 1December 17th 2022
Ophthalmology Times®' EyeCon co-chairs Peter J. McDonnell, MD, director of the Wilmer Eye Institute, and glaucoma specialist Oluwatosin U. Smith MD, from Glaucoma Associates of Texas, discuss some of the highlights of EyeCon 2022.
Monitor keratoconus progression after cross-linking treatmentNovember 30th 2022
Contemporary scleral lenses work so well that stable vision in them cannot necessarily be taken as a sign that KC progression has stopped. Determination of KC progression requires advanced imaging.
Alcon completes acquisition of Aerie PharmaceuticalsNovember 22nd 2022
The deal adds pharmaceutical research and development capabilities and further expertise for future product pipeline. It also expands Alcon’s presence in the $20 billion global ophthalmic pharmaceutical category.
EP. 5: EyeCon 2022: Last chance to earn those end-of-year CME creditsNovember 10th 2022
This December, the Ophthalmology Times® EyeCon 2022 at the JW Marriott Marco Island Beach Resort in Florida will provide attendees with an end-of-year opportunity to meet their continuing medical education requirements. This activity has been approved for 12.50 AMA PRA Category 1 Credits™.
Centricity Vision’s new ZEPTO Plus handpiece gives surgeons a choice in capsulotomy sizeOctober 26th 2022
CEO Rob Thornhill discusses the features of the device, as well as plans for a new technology called ZEPTOLINK which combines the company’s novel ZEPTO technology with any phaco device.